Mar 9, 2023 08:25AM

Mar 9, 2023 06:09AM

Mar 8, 2023 07:30PM

Mar 7, 2023 09:19AM

Mar 7, 2023 09:01AM

Mar 7, 2023 09:00AM

Mar 7, 2023 09:00AM F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma

Mar 6, 2023 09:45AM

Feb 23, 2023 08:34AM

Feb 9, 2023 09:00AM

Feb 1, 2023 08:45AM

Jan 18, 2023 07:51AM

Dec 30, 2022 08:34AM

Dec 29, 2022 09:32AM Form SC 14D9/A F-star Therapeutics, Filed by: F-star Therapeutics, Inc.

Dec 21, 2022 06:08AM

Dec 19, 2022 10:54AM

Dec 5, 2022 08:14AM

Nov 21, 2022 06:39AM

Nov 7, 2022 07:31AM

Nov 7, 2022 07:30AM

Nov 7, 2022 07:30AM F-star Therapeutics Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research

Nov 1, 2022 08:59AM

Oct 24, 2022 05:31PM

Oct 3, 2022 08:31AM

Sep 15, 2022 04:06PM

Aug 11, 2022 08:00AM

Aug 11, 2022 08:00AM

Aug 4, 2022 09:33AM Form SC 14D9/A F-star Therapeutics, Filed by: F-star Therapeutics, Inc.

Aug 4, 2022 07:00AM

Jul 25, 2022 05:28PM

Jul 8, 2022 07:01AM

Jul 8, 2022 07:00AM

Jul 7, 2022 11:40AM

Jun 23, 2022 07:31AM

Jun 23, 2022 07:30AM invoX Pharma to Acquire F-star Therapeutics, Inc. a Pioneering Next Generation Bispecific Discovery Platform and Clinical Programs

Jun 23, 2022 07:30AM

5,494 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All